Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Check-Cap Ltd.

Check-Cap Ltd. (CHEK) Stock Overview

Explore Check-Cap Ltd.’s financial performance, market position, analyst ratings, and future outlook.

CHEK●NASDAQ
HealthcareMedical - Diagnostics & Research
$1.86
$0.03(1.64%)
U.S. Market opens in 13h 56m

Check-Cap Ltd. (CHEK)

Meyka AI Score

Z

Key Financials

Market Cap10.9M
P/E Ratio-0.43
EPS (TTM)$-4.30
ROE-2.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CHEK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Check-Cap Ltd. (NASDAQ: CHEK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Check-Cap Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CHEK on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Check-Cap Ltd.'s NASDAQ-traded stock include a P/E ratio of -0.43 and a market capitalization of 10.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CHEK on the NASDAQ.

Price Performance (NASDAQ: CHEK)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-1.06%
Year-to-Date (YTD) Change
10.06%
1-Year Change
151.85%
3-Year Change
-30.34%
5-Year Change
-94.22%
All-Time (Max) Change
-99.87%

Contact Information

https://www.check-cap.com
972 4 830 3401
Check-Cap Building, Isfiya, NaN, 30090

Company Facts

850 Employees
IPO DateMar 4, 2015
CountryIL

Frequently Asked Questions